Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma.
Sai-Lan LiuLi-Juan BianZe-Xian LiuQiu-Yan ChenXue-Song SunRui SunDong-Hua LuoXiao-Yun LiBei-Bei XiaoJin-Jie YanZi-Jian LuShu-Mei YanLi YuanLin-Quan TangJian-Ming LiHai-Qiang MaiPublished in: Journal for immunotherapy of cancer (2021)
The immune signature provided a reliable estimate of distant metastasis risk in patients with NPC and might be applied to identify the cohort which benefit from IC+CCRT.
Keyphrases